Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
Clinical trial NCT00697970 · COMPLETED
Trial details
- NCT number
- NCT00697970
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1993-11-01
- Primary completion
- 1995-04-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.